NEW YORK (
) is trading at unusually high volume Thursday with six million shares changing hands. It is currently at four times its average daily volume and trading up $2.92 (+5.1%) at $60.25 as of 3:36 p.m. ET.
Illumina has a market cap of $8.6 billion and is part of the
industry. Shares are down 9.5% year to date as of the close of trading on Wednesday.
Illumina, Inc. develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company has a P/E ratio of 61.1, below the average drugs industry P/E ratio of 80.1 and above the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates Illumina as a
. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations, increase in net income, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. You can view the full
See all heavy volume stocks in our
or get investment ideas from our
Interested in other stocks that are rising on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting
to 95370 or select from